These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2516529)

  • 21. Interspecies comparison of the pharmacokinetics of aldose reductase inhibitors.
    Brazzell RK; Park YH; Wooldridge CB; McCue B; Barker R; Couch R; York B
    Drug Metab Dispos; 1990; 18(4):435-40. PubMed ID: 1976064
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Disposition of the aldose reductase inhibitor AL01576 in rats.
    Park YH; Wooldridge CB; Mattern J; Stoltz ML; Brazzell RK
    J Pharm Sci; 1988 Feb; 77(2):110-5. PubMed ID: 3129545
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aldose reductase in diabetic complications of the eye.
    Kinoshita JH; Fukushi S; Kador P; Merola LO
    Metabolism; 1979 Apr; 28(4 Suppl 1):462-9. PubMed ID: 45423
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Galactose-induced retinal microangiopathy in rats.
    Kern TS; Engerman RL
    Invest Ophthalmol Vis Sci; 1995 Feb; 36(2):490-6. PubMed ID: 7843917
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Morphological classification of the prevention by aldose reductase inhibitor of rat galactosemic cataract].
    Akagi Y; Ikebe H; Terubayashi H; Takahashi Y; Tsuji T
    Nippon Ganka Gakkai Zasshi; 1989 Apr; 93(4):494-500. PubMed ID: 2508449
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevention or moderation of some ultrastructural changes in the RPE and retina of galactosemic rats by aldose reductase inhibition.
    Vinores SA; Campochiaro PA
    Exp Eye Res; 1989 Sep; 49(3):495-510. PubMed ID: 2507341
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of aldose reductase inhibitor, CT-112, on sugar alcohol accumulation in corneal epithelium of galactose-fed rats.
    Awata T; Sogo S; Yamamoto Y
    Jpn J Ophthalmol; 1986; 30(3):245-50. PubMed ID: 3097363
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effects of an aldose reductase inhibitor upon the sorbitol pathway, fructose-1-phosphate and lactate in the retina and nerve of streptozotocin-diabetic rats.
    Poulsom R; Mirrlees DJ; Earl DC; Heath H
    Exp Eye Res; 1983 May; 36(5):751-60. PubMed ID: 6406254
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of an aldose reductase inhibitor, 1-[(p-bromophenyl)-sulfonyl]hydantoin, on cataract formation and tissue polyol levels in galactosemic rats.
    Okuda J; Yashima K; Inagaki K; Miwa I
    Chem Pharm Bull (Tokyo); 1985 Jul; 33(7):2990-5. PubMed ID: 3936627
    [No Abstract]   [Full Text] [Related]  

  • 30. Polyol pathway in tissues of spontaneously diabetic Chinese hamsters (Cricetulus griseus) and the effect of an aldose reductase inhibitor, ONO-2235.
    Sekiguchi M; Watanabe K; Eto M; Iwashima Y; Morikawa A; Takahashi M; Ishii K; Makino I
    Comp Biochem Physiol B; 1991; 98(4):637-40. PubMed ID: 1907900
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tolrestat pharmacokinetics in rat peripheral nerve.
    Dvornik D; Millen J; Hicks DR; Kraml M
    J Diabetes Complications; 1994; 8(1):18-26. PubMed ID: 8167382
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Galactosemia produces ARI-preventable nodal changes similar to those of diabetic neuropathy.
    Kamijo M; Basso M; Cherian PV; Hohman TC; Sima AA
    Diabetes Res Clin Pract; 1994 Sep; 25(2):117-29. PubMed ID: 7821191
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The protein binding of phenytoin, propranolol, diazepam, and AL01576 (an aldose reductase inhibitor) in human and rat diabetic serum.
    McNamara PJ; Blouin RA; Brazzell RK
    Pharm Res; 1988 May; 5(5):261-5. PubMed ID: 3149736
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Statil-sensitive polyol formation in nerve of galactose-fed mice.
    Calcutt NA; Willars GB; Tomlinson DR
    Metabolism; 1988 May; 37(5):450-3. PubMed ID: 3130544
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relative importance of aldose reductase versus nonenzymatic glycosylation on sugar cataract formation in diabetic rats.
    Kador PF; Lee JW; Fujisawa S; Blessing K; Lou MF
    J Ocul Pharmacol Ther; 2000 Apr; 16(2):149-60. PubMed ID: 10803425
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of aldose reductase in five tissues of the streptozotocin-diabetic rat.
    Poulsom R; Heath H
    Biochem Pharmacol; 1983 May; 32(9):1495-9. PubMed ID: 6407486
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevention of retinal vessel changes associated with diabetic retinopathy in galactose-fed dogs by aldose reductase inhibitors.
    Kador PF; Akagi Y; Takahashi Y; Ikebe H; Wyman M; Kinoshita JH
    Arch Ophthalmol; 1990 Sep; 108(9):1301-9. PubMed ID: 2119169
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diabetic-like retinopathy ameliorated with the aldose reductase inhibitor WAY-121,509.
    Robinson WG; Laver NM; Jacot JL; Glover JP; Basso MD; Blouin P; Hohman TC
    Invest Ophthalmol Vis Sci; 1996 May; 37(6):1149-56. PubMed ID: 8631629
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of aldehyde reductase by aldose reductase inhibitors.
    Sato S; Kador PF
    Biochem Pharmacol; 1990 Sep; 40(5):1033-42. PubMed ID: 2117925
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevention of defects of axonal transport and nerve conduction velocity by oral administration of myo-inositol or an aldose reductase inhibitor in streptozotocin-diabetic rats.
    Mayer JH; Tomlinson DR
    Diabetologia; 1983 Nov; 25(5):433-8. PubMed ID: 6197336
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.